Conavi Medical Corp. CNVIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -90.74% | -91.78% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.74% | -91.78% | -- | -- | -- |
| Cost of Revenue | -98.25% | -98.55% | -- | -- | -- |
| Gross Profit | -88.77% | -89.54% | -- | -- | -- |
| SG&A Expenses | 28.96% | 3.15% | -- | -- | -- |
| Depreciation & Amortization | -0.13% | -11.22% | -- | -- | -- |
| Other Operating Expenses | 2.58% | 2.58% | -- | -- | -- |
| Total Operating Expenses | -11.83% | -31.94% | -- | -- | -- |
| Operating Income | -33.58% | 3.92% | -- | -- | -- |
| Income Before Tax | 30.76% | 54.63% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.76% | 54.63% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.76% | 54.63% | -- | -- | -- |
| EBIT | -33.58% | 3.92% | -- | -- | -- |
| EBITDA | -34.33% | 3.83% | -- | -- | -- |
| EPS Basic | 92.08% | 95.55% | -- | -- | -- |
| Normalized Basic EPS | 86.37% | 93.30% | -- | -- | -- |
| EPS Diluted | 92.08% | 95.55% | -- | -- | -- |
| Normalized Diluted EPS | 86.37% | 93.30% | -- | -- | -- |
| Average Basic Shares Outstanding | 124.64% | 233.42% | -- | -- | -- |
| Average Diluted Shares Outstanding | 124.64% | 233.42% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |